WHO SHOULD RECEIVE BLOOD?

Whole Blood

Symptomatic anemia with large volume deficit

Packed Red Blood Cells

Symptomatic anemia

Washed Red Blood Cell

Symptomatic anemia on patients with history of severe allergic or anaphylactic reactions

Leuko-reduced/ Leuko- poor components

Prevents febrile transfusion reaction and transfusion-related acute lung injury (TRALI) caused by antibodies against WBCs, to reduce CMV transmission

Irradiated blood components

To prevent graft-vs-host-disease

Neocyte-enriched red blood cells

To prolong time between transfusions in chronically transfusion-dependent patients (e.g. sickle cell anemia or thalassemia)

Random Donor Platelets

Bleeding due to quantitative or qualitative platelet defect

Single Donor Platelets

Bleeding due to quantitative or qualitative platelet defect, prevention of HLA alloimmunization

Fresh Frozen Plasma

multiple coagulation factor deficiency

Cryoprecipitate

Treatment of patients with von Willebrand's disease, hemophilia A (factor VIII deficiency), or hypofibrinogenemia who are bleeding, or at risk of bleeding; disseminated intravascular coagulation

Granulocyte Concentrates

To elevate the leukocyte count in patients with neutropenia or granulocyte dysfunction who are suffering from, or at risk of, a life-threatening infection; Neutropenia with infection unresponsive to antibiotics

Factor Concentrates

Specific coagulation factor deficiencies

Immune Serum Globulin (ISG)

Patients with congenital hypogammaglobulinemia